People

Ashly Jordan
Ashly E. Jordan, PhD, MPH
NYS Office of Addiction Services and Supports (OASAS) - Director of Research and Program Evaluation
Education
PhD, Epidemiology, Graduate School of Public Health and Health Policy, City University of New York
MPH, Biostatistics and Epidemiology, School of Public Health, City University of New York
Research Interests
Societal (structural, social, and political) determinants of population health and inequities, infectious disease epidemiology, people who use drugs, hepatitis C virus, HIV, multi-level data analysis
BIO
Ashly Jordan is the Director of Research and Program Evaluation for the New York State Office of Addiction Services and Supports. She is an interdisciplinary epidemiologist with more than 15 years of applied research experience and public health practice focused on understanding how systems and interventions can improve health and social outcomes for people who use substances and who experience addiction. She has served as a consultant to the United Nations Office on Drugs and Crime. Dr. Jordan’s research has examined blood-borne and skin and soft tissue infections, tuberculosis, drug overdose, substance use epidemiology, and the impact of criminal legal involvement on substance use epidemiology and treatment trajectories. She has published extensively, including on prevention and care continua, Big Events theory, and novel metrics, and has served on study sections. Drawing on theory-based multi-level understanding of illness and health, and principles of health equity and social justice, Dr. Jordan’s research and public health practice has focused on the interplay between individual, social and structural factors on people who use substances.
Projects
Principal Investigator, Leveraging Regulatory Flexibility for Methadone Take-home Dosing to Improve Retention in Treatment for Opioid Use Disorder: A Stepped-wedge Randomized Trial to Facilitate Clinic Level Changes. Active
Principal Investigator, Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach. Active
Publications

Recent

Zang X, Skinner A, Li Z, Shaw LC, Behrends CN, Chatterjee A, Jalali A, Jordan AE, Morgan JR, Nolen S, Schackman BR, Marshall BDL, Walley AY (2024).
Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States
Addiction [Epub 2024 Oct 25]. doi: 10.1111/add.16691.

Jordan AE, Jette G, Graham JK, Burke C, Cunningham CO (2024).
Drug overdose death following substance use disorder treatment termination in New York City: A retrospective longitudinal cohort study
Journal of Urban Health, 101 (5), 1045-1057. doi: 10.1007/s11524-024-00893-5. PMCID: PMC11461374.

Aleksanyan J, Choi S, Lincourt P, Burke C, Ramsey KS, Hussain S, Jordan AE, Morris M, D'Aunno T, Glied S, McNeely J, Elbel B, Mijanovich T, Adhikari S, Neighbors CJ (2024).
Lost in transition: A protocol for a retrospective, longitudinal cohort study for addressing challenges in opioid treatment for transition-age adults
PLoS One, 19 (8), e0297567. doi: 10.1371/journal.pone.0297567. PMCID: PMC11324150.

Kapadia SN, Jordan AE, Eckhardt BJ, Perlman DC (2024).
The urgent need to implement point-of-care RNA testing for hepatitis C virus to support elimination
Clinical Infectious Diseases, 78 (5), 1235-1239. doi: 10.1093/cid/ciad503. PMCID: PMC11093654.

Jordan AE, Bachhuber MA, Tuazon E, Jimenez C, Lincourt P, Hussain S, Rubinfeld J, Cunningham CO (2024).
Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations
Drug and Alcohol Dependence, 258, 111283. doi: 10.1016/j.drugalcdep.2024.111283. PMCID: PMC11088491.


Notable

Jordan AE, Des Jarlais DC, Arasteh K, McKnight C, Nash D, Perlman DC (2015).
Incidence and prevalence of hepatitis C virus infection among persons who inject drugs in New York City: 2006-2013
Drug and Alcohol Dependence, 152, 194-200. doi: 10.1016/j.drugalcdep.2015.03.039. PMCID: PMC4458155.

Hagan H, Jordan AE, Neurer J, Cleland CM (2015).
Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men
AIDS, 29 (17), 2335-2345. doi: 10.1097/QAD.0000000000000834. PMCID: PMC4640945.

Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC (2015).
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential
International Journal of Drug Policy, 26 (11), 1056-1063. doi: 10.1016/j.drugpo.2015.04.015. PMCID: PMC4581906.

Ashly Jordan's MyBibliography Profile